JAMA
LightNews LightNews
banner
jama.com
JAMA
@jama.com
22K followers 110 following 2.9K posts
JAMA is an international peer-reviewed general medical journal and a member of the JAMA Network family of journals.

🌐 JAMA.com
Posts Replies Media Videos
jama.com
Heat-related EMS activations increased 65% from 2019 to 2024, with the fastest increases among middle-aged adults, lower-middle–income communities, and in the Mountain and West South Central US.

bit.ly/4tqmVq0
JAMA research letter titled 'Climate Change and Health: Trends and Disparities in Heat-Related Emergency Medical Services Activations.' Table shows EMS activation rates from 2019-2024 by population, heat-related, non-heat-related changes, and rate ratios.
February 9, 2026 at 3:00 PM
jama.com
💬 Perspective: #MedEd accreditation should shift from process-focused standards to outcome-based measures, with leadership from education experts ensuring assessment aligns with professional and public expectations.

bit.ly/4bJcBTM
A page from JAMA with the title "A Call for Education Leadership in Accreditation Reform" by David T. Stern, Monica L. Lypson, and Frederic W. Hafferty. Published online February 2, 2026. The article discusses physician accreditation.
February 9, 2026 at 1:00 PM
jama.com
📢 Special Communication: Opportunistic salpingectomy during pelvic or selected abdominal surgery is associated with lower risk of tubo-ovarian #carcinoma and minimal #surgical risk, but data on long-term #ovarian function remain limited.

bit.ly/3Ov7a11
Figure outlines eight-step consensus statement development for opportunistic salpingectomy in tubo-ovarian carcinoma prevention. Steps include multidisciplinary group nomination, clinical question identification, scientific evidence, preliminary consensus, and discussion.
February 9, 2026 at 12:00 PM
jama.com
Heat-related EMS activations increased 65% from 2019 to 2024, with the fastest increases among middle-aged adults, lower-middle–income communities, and in the Mountain and West South Central US.

bit.ly/4cgd00a
JAMA Research Letter: Climate Change and Health. Trends and Disparities in Heat-Related Emergency Medical Services Activations. Published online Feb 4, 2026. Table shows EMS activation trends by population, 2019-2024. Data includes heat-related, non-heat related, and change percentages.
February 8, 2026 at 5:00 PM
jama.com
💬 Viewpoint: Removal of black box warnings for menopausal hormone therapy reflects evidence that the risks and benefits of MHT vary by patient context, including hormone receptor status, MHT formulation, and timing post-menopause.

bit.ly/4aB8h7X
JAMA article: 'What Systemic Hormone Therapy Black Box Removal Means for Breast Cancer Survivors' by Versha Pleasant, Kari Ring. Published February 5, 2026. It discusses the FDA's removal of black box warnings for menopausal hormone therapy (MHT).
February 8, 2026 at 4:00 PM
jama.com
In this podcast, JAMA Deputy Editors Linda Brubaker, MD, and Preeti Malani, MD, MSJ, discuss the latest science published in JAMA:

➡️ Uncontrolled Hypertension in US Adults,
➡️ Tenecteplase for Ischemic Stroke After 4.5 Hours, and more.

🎧 Listen now:
bit.ly/4aoYlgR
Two copies of JAMA(Journal of the American Medical Association) are stacked. The post below highlights “Uncontrolled Hypertension in US Adults, Tenecteplase for... JAMA Editors' Summary” with a play button below.
February 8, 2026 at 3:00 PM
jama.com
This JAMA Patient Page describes nitrous oxide misuse, potential complications of acute and long-term misuse, and treatment and prevention measures.

bit.ly/4aB8hot
Info sheet: "Nitrous oxide misuse involves the recreational inhalation of nitrous oxide gas (also known as laughing gas) and can cause severe health complications." Details sources, inhalation methods and health risks.
February 8, 2026 at 2:00 PM
jama.com
💬 Viewpoint: Approval of leucovorin for cerebral folate deficiency based on limited evidence raises concerns about weakening FDA drug approval standards and public trust.

bit.ly/4tpgZxu
JAMA viewpoint: "The FDA's Leucovorin Approval—A Departure From Evidentiary Standards" by Daniel G. Aaron, Michael S. Sinha, and I. Glenn Cohen. Published online December 22, 2025. Discusses FDA approval of Wellcovorin for autism treatment.
February 8, 2026 at 1:00 PM
jama.com
Problematic social media or phone use was associated with increased smartphone time in school, especially on social apps, among US adolescents; disparities in use were observed by age, race, and household income.

bit.ly/4bGmtOf
A table titled 'Table 1. Sociodemographic and Descriptive Characteristics of Study Sample (N = 640) (continued)' from JAMA, showing smartphone use during school hours by US youth. It lists screen use variables with their No.(%)a, Mean (SD), and Median (IQR) values.
February 8, 2026 at 12:00 PM
jama.com
📊 Research Summary: In patients with non–large-vessel occlusion stroke and salvageable tissue, tenecteplase extended to 24 hours improved outcomes compared with standard care but increased bleeding risk.

bit.ly/4qqA7su
JAMA Research Summary: Tenecteplase for Acute Non-Large Vessel Occlusion Ischemic Stroke. Key findings: Tenecteplase group had 43.6% excellent outcome vs 34.2% in standard care. Trial details, safety outcomes, and limitations are noted.
February 7, 2026 at 5:00 PM
jama.com
💬 Viewpoint: Removal of black box warnings for menopausal hormone therapy reflects evidence that the risks and benefits of MHT vary by patient context, including hormone receptor status, MHT formulation, and timing post-menopause.

bit.ly/4aBpz4T
JAMA article "What Systemic Hormone Therapy Black Box Removal Means for Breast Cancer Survivors" by Versha Pleasant and Kari Ring, published online February 5, 2026. It discusses removing black box warnings for menopausal hormone therapy (MHT).
February 7, 2026 at 4:00 PM
jama.com
Recent research on #COVID-19 mRNA vaccine-associated #myocarditis explores cytokine-driven mechanisms behind this cardiac complication.

This podcast discusses cytokine elevation and the potential role of genistein in reducing vaccine-induced myocardial injury.

bit.ly/4ag80Gf
A graphic shows a head filled with medical symbols like a heart, stethoscope, ambulance, prescription, and vaccine, representing "Understanding COVID-19 Vaccine-Associated Myocarditis, JAMA Medical News."
February 7, 2026 at 3:00 PM
jama.com
In patients with non–large-vessel occlusion stroke and salvageable tissue, tenecteplase extended to 24 hours improved outcomes compared with standard care but increased bleeding risk.

bit.ly/4bEDaJV
JAMA infographic: "Does intravenous tenecteplase improve clinical outcomes for stroke patients?" Study: tenecteplase showed a greater likelihood of excellent functional outcome at 90 days versus standard care, but increased hemorrhage risk. Population: 370 male, 196 female.
February 7, 2026 at 2:00 PM
jama.com
@who.int issued its first guideline on #GLP-1 medications for obesity.

Here’s what to know about the recommendations.

bit.ly/3Zn2pcb
6 Takeaways from the WHO’s First Obesity Drug Guideline
This Medical News article discusses key learnings from new World Health Organization guidance on the use of glucagon-like peptide-1 (GLP-1) medications for the treatment of obesity in adults.
bit.ly
February 7, 2026 at 1:00 PM
jama.com
💬 Viewpoint: Health care costs rank as the top everyday expense concern for US households, making health care affordability a decisive economic issue in upcoming elections and policy debates.

bit.ly/3Zox20Z
JAMA viewpoint: "As the 2026 Election Takes Shape, Health Care Is Becoming an Economic Issue for US Voters." A poll assessing economic concerns shows worry levels about affording healthcare, bills, rent, utilities, food, transport, and health insurance.
February 7, 2026 at 12:00 PM
jama.com
Researchers are untangling the mechanisms behind myocarditis after #COVID-19 mRNA vaccination, an extremely rare adverse effect.

bit.ly/4bEnBBW

#MedSky
Possible Mechanisms Emerge for Vaccine-Associated Myocarditis
This Medical News article discusses a new study that investigates immunological factors that may be involved in rare cases of heart muscle inflammation after COVID-19 vaccination.
bit.ly
February 6, 2026 at 6:05 PM
jama.com
🌙🫀Heart attacks tend to be less severe at night, but why?

bit.ly/4qo2W8O

#MedSky
Why Are Daytime Heart Attacks Worse?
This Medical News article discusses a new study that may reveal why myocardial infarctions tend to be less severe at night and how modulating the circadian rhythms of an immune cell may be a key to le...
bit.ly
February 6, 2026 at 6:05 PM
jama.com
💬 Viewpoint: Panelists who advised removing box warnings from #Menopausal hormone therapies were selected outside the standard FDA advisory process, lacked public input, and did not review all available evidence.

bit.ly/4rBjECJ
An article titled 'Menopausal Hormone Labels Should Rely on Evidence, Not Opinion' from JAMA. The article discusses the FDA's intention to remove box warnings from estrogen and hormone replacement therapy. It also contains Table. A US Food and Drug Administration (FDA) Advisory Committee vs the Menopause Expert Panel
February 6, 2026 at 4:05 PM
jama.com
💬 Editorial: In prospective analysis, the updated PECARN rule accurately stratified risk for invasive bacterial infections in full-term febrile neonates, identifying a sizable low-risk group for whom invasive testing may be unnecessary.

bit.ly/4rBjQSt
JAMA, Published online December 8, 2025. Editorial titled: Moving the Field Forward to Safely Do Less With Febrile Neonates by Justin B. Searns, MD; Sean T. O'Leary, MD, MPH. Text discusses newborns with suspected infections.
February 6, 2026 at 3:00 PM
jama.com
Among patients with acute ischemic #stroke due to non–large vessel occlusion, #tenecteplase administered 4.5 to 24 hours after symptom onset increased excellent outcomes but raised the risk of intracranial #hemorrhage. #ISC26

📽️ Watch the video & read the full study: bit.ly/4kgH1yQ
February 6, 2026 at 2:37 PM
jama.com
The updated PECARN rule reliably identified low-risk febrile infants, with no missed cases of bacterial meningitis, potentially reducing routine lumbar punctures.

bit.ly/3Zkwf1a
JAMA | Original Investigation: "Prediction of Bacteremia and Bacterial Meningitis Among Febrile Infants Aged 28 Days or Younger." Key points discuss accuracy of clinical prediction rules based on lab results to identify risk in young infants.
February 6, 2026 at 2:00 PM
jama.com
Millions of people are turning to #AI chatbots for mental health support, but is it safe and regulated?

Here’s what experts have to say.

bit.ly/4tq0amk
The Rise of Therapy Chatbots
This Medical News article discusses the growing use of generative artificial intelligence chatbots as sources of mental health support.
bit.ly
February 6, 2026 at 1:00 PM
jama.com
💬 Viewpoint: Adversarial collaboration is designed to move beyond traditional replication and consensus-building by engaging credible experts from opposing viewpoints to jointly resolve disputes in #BiomedicalScience.

bit.ly/4ko1gLl
An article titled "Adversarial Collaboration as a Strategy for Credible Biomedical Science" by David M. Kent, MD, MS; John P. A. loannidis, MD, DSc in JAMA, published online February 5, 2026. Article discusses public trust in science.
February 6, 2026 at 12:00 PM
jama.com
📊 Research Summary: In patients with non–large-vessel occlusion stroke and salvageable tissue, tenecteplase extended to 24 hours improved outcomes compared with standard care but increased bleeding risk.

#ISC26 @ahascience.bsky.social

bit.ly/4rsfgpp
JAMA Research Summary: Tenecteplase for Acute Non-Large Vessel Occlusion Ischemic Stroke. Key findings: Tenecteplase group had 43.6% excellent outcome vs 34.2% in standard care. Trial details, safety outcomes, and limitations are noted.
February 5, 2026 at 5:50 PM
jama.com
In patients with non–large-vessel occlusion stroke and salvageable tissue, tenecteplase extended to 24 hours improved outcomes compared with standard care but increased bleeding risk.

#ISC26 @ahascience.bsky.social

bit.ly/4ksD4Y3
JAMA infographic about tenecteplase for stroke: 370 male, 196 female patients with non-large vessel occlusion stroke, mean age 68. Intervention: 570 patients randomized; 286 got tenecteplase, 284 standard care. Findings: tenecteplase had higher likelihood of excellent outcome.
February 5, 2026 at 5:35 PM